Adding to its line of Smart Port CT power-injectable ports, AngioDynamics has introduced its new Low-Profile and Mini models of the device. The ports are designed to provide doctors with repeated access to blood vessel over an extended period, while reducing potential damage. Both of the new devices are MRI conditional, and both have been granted FDA clearance and European CE marking.
From the press release:
Both of the new Smart Port CT models feature AngioDynamics’ market-leading titanium port technology and the unique, patented Vortex port technology that allows for superior fluid dynamics to help prevent dead spaces and the formation of sludge, thus extending the working life of the port. These new models are indicated for power injection of contrast media with a flow rate of 5mL/sec.
In a clinical trial comparing the Smart Port’s Vortex port technology to conventional ports, Vortex port technology had a nearly 75% reduction in the occlusion rate as compared to conventional ports. Third party analysis found that on average a system with Vortex port technology can save $1,224 per patient over the life of the port.